Patients Struggle With Lack of Consistent Coverage for New Weight-Loss Drugs

(MedPage Today) -- Supplies of high-demand obesity treatments are improving, but that doesn't mean it's easier to get them.
Many employers and insurers are scaling back coverage of semaglutide (Wegovy) and tirzepatide (Zepbound) and a key government...